Latest Sales Growth News

Briscoe Group Limited has reported record sales for both the fourth quarter and full-year 2026, alongside improved gross margins and a growing online presence.

Orthocell Ltd reports steady progress in commercialising its nerve repair product Remplir in the US, with sales growth, expanded distributor networks, and manufacturing upgrades underpinning its path to profitability.

KMD Brands reports strong sales momentum in the first five months of FY26, led by Kathmandu’s impressive growth in Australia and New Zealand, while EBITDA guidance signals a significant profit uplift.

BPH Global has reported record sales in its Indonesian seaweed operations alongside completing a $1.1 million capital raise and advancing promising R&D projects. The company is scaling its trading platform and expanding into bio-stimulants and wellness products as it enters 2026.

AVADA Group Limited reported a robust 24% increase in cash receipts for Q2 FY26, driven by strong sales and strategic leadership changes, while expanding its trade finance facility to support ongoing growth.

Oldfields Holdings reports steady progress in its turnaround strategy, cutting costs and reallocating assets to stronger regions while preparing for a capital raise and potential acquisitions.

KNeoMedia advances its KneoScience platform with new orders and high school expansion, while actively working to lift its ASX trading suspension through cost cuts and funding initiatives.

Freehill Mining Limited reported a robust 46% increase in quarterly sales, driven by strong demand at its Islon aggregate site and steady contributions from Yerbas Buenas. Meanwhile, the company advances promising copper and gold project assessments.

ReNerve Limited reported a robust 80% increase in quarterly sales driven by strong US market adoption and expanded hospital approvals. The company advances its nerve repair product pipeline with key regulatory milestones and a refreshed board.

CONNEQT Health Limited reported a strong quarter with over 200% sales growth for its CONNEQT Pulse product and completed a $3.1 million institutional placement, while operational cost reductions support a leaner business model.

RooLife Group Limited (ASX, RLG) reported a strong Q2 FY2026 with revenue climbing to $3.25 million, driven by rapid growth in its RLG Coffee range in China. The company’s lean, data-driven marketplace model is scaling efficiently despite expected seasonal slowdowns.

OncoSil Medical has reported a record quarter for dose sales alongside key European market entries and a successful manufacturing milestone, signalling growing momentum for its pancreatic cancer treatment.